Boyds hosted an online workshop focusing on early drug development on the 16 July.
Members of the Boyds Consulting Team took delegates through early drug development activities, which can often be complex, and explained the do’s and don’ts when planning a CTA/IND-enabling programme. The team focused on aligning development and regulatory activities and the importance of integrated development plans, helping achieve accelerated development.
Clip one: Non-clinical development programmes to support first-in-human studies
Clip two: Integrated development planning
Clip three: Preparing clinical trial applications
Clip four: Orphan drug designations and accelerated access
Q&A and slides
During the webinar, delegates were able to post questions to the panel. These have now been collated and can be viewed here with the responses.
A full copy of the slides is available here.